Valproic | Remedyrepack Inc. Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Valproic | Remedyrepack Inc. while breastfeeding. We will also discuss about common side effects and warnings associated with Valproic | Remedyrepack Inc..

What is Valproic | Remedyrepack Inc. used for?


Valproic Acid is an anti-epileptic drug indicated for: Monotherapy and adjunctive therapy of complex partial seizures; sole and adjunctive therapy of simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures ( 1) 1.1 Epilepsy Valproic Acid is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Valproic Acid is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. Simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. Complex absence is the term used when other signs are also present. See Warnings and Precaution ( 5.1 ) for statement regarding fatal hepatic dysfunction. 1.2 Important Limitations Because of the risk to the fetus of decreased IQ, neural tube defects, and other major congenital malformations, which may occur very early in pregnancy, valproate should not be administered to a woman of childbearing potential unless the drug is essential to the management of her medical condition [see Warnings and Precautions ( 5.2 , 5.3 , 5.4 ) , Use in Specific Populations ( 8.1 ) , and Patient Counseling Information ( 17 ) ].

I am breastfeeding mother and I am using Valproic | Remedyrepack Inc.. Can it have any bad effect on my kid? Shall I search for better alternative?

Valproic | Remedyrepack Inc. safe for breastfeeding
As per our analysis Valproic | Remedyrepack Inc. contains only one ingredient and that is Valproic acid. We have analyzed Valproic acid and it seems to be safe to use Valproic acid while breastfeeding, that means usage of Valproic | Remedyrepack Inc. shall be safe while breastfeeding. Below you can check more details of Valproic acid usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Valproate is excreted in human milk. Caution should be exercised when valproate is administered to a nursing woman.

Valproic | Remedyrepack Inc. Breastfeeding Analsys


Valproic acid while Breastfeeding

Safe

CAS Number: 99-66-1

It is excreted in breast milk in clinically non-significant amount without problems in the short or long term in infants whose mothers were treated. Plasma levels of these infants were undetectable or very low. Cognitive development did not suffer any alteration. An infant was presented with thrombocytopenic purpura and anemia who recovered after removing valproate in the mother. However, doubts were raised on whether it was instead a post-viral reaction that led to idiopathic thrombocytopenic purpura. The administration of valproic acid does not affect prolactin levels. The American Academy of Pediatrics rates it as usual compatible with breastfeeding medication.WHO List of Essential Medicines 2002: compatible with breastfeeding.

Valproic | Remedyrepack Inc. Breastfeeding Analsys - 2


Valproic acid while Breastfeeding

CAS Number: 99-66-1

Valproic | Remedyrepack Inc. and breastfeeding

Breastfeeding during valproic acid monotherapy does not appear to adversely affect infant growth or development, and breastfed infants had higher IQs and enhanced verbal abilities than nonbreastfed infants at 6 years of age in one study.[1] If valproic acid is required by the mother, it is not necessarily a reason to discontinue breastfeeding. Because of the low levels of valproic acid in breastmilk and infant serum, no definite adverse reactions to valproic acid during breastfeeding have been reported. Theoretically, breastfed infants are at risk for valproic acid-induced hepatotoxicity, so infants should be monitored for jaundice and other signs of liver damage during maternal therapy. A questionable case of thrombocytopenia has been reported, so monitor the infant for unusual bruising or bleeding. One author recommends monitoring infant serum valproate levels, platelets and liver enzymes during therapy.[1] Combination therapy with sedating anticonvulsants or psychotropics may result in infant sedation or withdrawal reactions.

Is Valproic | Remedyrepack Inc. safe while breastfeeding

What should I do if already breastfed my kid after using Valproic | Remedyrepack Inc.?

As usage of Valproic | Remedyrepack Inc. is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Valproic | Remedyrepack Inc. else no further action is required.


I am nursing mother and my doctor has suggested me to use Valproic | Remedyrepack Inc., is it safe?

Usage of Valproic | Remedyrepack Inc. is safe for nursing mothers and baby, No worries.


If I am using Valproic | Remedyrepack Inc., will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Valproic | Remedyrepack Inc. in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Divalproex Sodium Pellet
Divalproex Sodium Dr | Divalproex Sodium Tablet, Delayed Release
Divalproex Sodium Er | Divalproex Sodium Tablet, Film Coated, Extended Release
Depakote | Divalproex Sodium Tablet, Delayed Release
Depakote Sprinkles | Divalproex Sodium Capsule
Depakene | Valproic Acid Capsule
Divalproex Sodium Delayed Release (sprinkle) | Divalproex Sodium Capsule